UNSPSC 51332901: Bromerguride
Commodity
Code facts
- Part of
-
-
51000000
-
51330000
- 51332900
-
51330000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51332901
Definition
This classification denotes a dopamine antagonist with the molecular formula C20H25BrN4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HX58M2377W, chemically known as 3-(2-bromo-9,10-didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea but generally known as bromerguride, which bears US NIH Compound Identifier 71266. European Medicines Agency schedules Bromerguride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05911MIG.
Read the full definition
The term BROMERGURIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BROMERGURIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bromerguride under HS 29396900 and SITC 54146. As of Q4 2014, BROMERGURIDE remains the US FDA Preferred Term for this commodity. Bromerguride bears US NLM identifiers UMLS ID C0054092 and NCI Concept Code C73311. SMILES: BRC1[NH]C2C3C1CC1N(CC(NC(=O)N(CC)CC)C=C1C3CCC2)C.
About UNSPSC 51332901
UNSPSC 51332901 Bromerguride is a Commodity code that, based on recent state and local solicitation activity, actually encompasses naloxone and drug deactivation systems procured by county health departments and community health initiatives. Naloxone — a medication used to reverse opioid overdoses — and accompanying safe drug deactivation systems represent the concrete products being bought under this code, reflecting broader state and local efforts to support overdose response and substance-abuse harm reduction. Issuing bodies soliciting under this code include county-level health departments and facilities operating community health programs; the recent opportunity suggests county purchasing offices serve as the primary procurement vehicle for these supplies.
Seminole County, Florida posted an IFB (Invitation for Bid) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The procurement requires vendors to include all shipping and delivery costs in their proposals, maintain workers' compensation and liability insurance, comply with drug-free workplace and E-Verify requirements, and accept a two-year initial contract term with a one-year renewal option and a three-month probationary termination clause. The solicitation indicates potential FEMA funding and adherence to federal environmental regulations (Clean Air Act, Federal Water Pollution Control Act). Geographic activity under this code appears concentrated in Florida; the source provides no evidence of recent solicitations from other states or regions.
Quick answers
What is UNSPSC 51332901?
UNSPSC 51332901 is Bromerguride, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51332901?
UNSPSC 51332901 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51332901
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code